Pleural Diffuse Malignant Mesothelioma — Trials

Pleural Diffuse Malignant Mesothelioma — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–7 of 7 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05647265	Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma	recruiting	Phase 2	26	Alliance for Clinical Trials in OncologyOTHER	1	Aug 5, 2026	clinicaltrials
NCT03228537	Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma	active not recruiting	Phase 1	28	National Cancer Institute (NCI)NIH	1	Aug 4, 2026